B.infantis enhances immunotherapy for Guillain-Barre syndrome through regulating PD-1

Abstract Background Guillain-Barré syndrome (GBS) is a rare, autoimmune disease. B.infantis is reported to be effective in alleviating GBS by regulating abnormal function of T helper (Th) cells. Objectives In this study, T cells were isolated from healthy and GBS patients. The therapeutic effect of...

Full description

Bibliographic Details
Main Authors: Peng Shi, Di Nian, Hongdang Qu, Ming Ye, Chun Wang, Li Li, Qian Li
Format: Article
Language:English
Published: BMC 2023-01-01
Series:BMC Neurology
Subjects:
Online Access:https://doi.org/10.1186/s12883-022-03046-w
_version_ 1811175851341905920
author Peng Shi
Di Nian
Hongdang Qu
Ming Ye
Chun Wang
Li Li
Qian Li
author_facet Peng Shi
Di Nian
Hongdang Qu
Ming Ye
Chun Wang
Li Li
Qian Li
author_sort Peng Shi
collection DOAJ
description Abstract Background Guillain-Barré syndrome (GBS) is a rare, autoimmune disease. B.infantis is reported to be effective in alleviating GBS by regulating abnormal function of T helper (Th) cells. Objectives In this study, T cells were isolated from healthy and GBS patients. The therapeutic effect of Bifidobacterium infantis (B.infantis) and whether it is achieved by PD-1 was examined at cellular and animal models. Methods We used CCK-8, flow cytometry and real-time PCR to determine the differentiation of T cell subsets at cellular level. Then, an experimental autoimmune neuritis (EAN) animal model using six-week SD rats (n = 30, male) weighing 180–200 g was established to support the role of B. infantis in GBS through PD-1. Results B. infantis inhibited the proliferation and promoted apoptosis of T cells from GBS. At the same time, the expression levels of PD-1 increased, which was correlated with decreased T-bet (Th1) and ROR-γt (Th17) and increased Foxp3 (Treg) expression. Moreover, B. infantis alleviated the symptoms of GBS. Th1 and Th17 cells decreased while Treg cells increased after B. infantis treatment, which could be partly abrogated by PD-1 inhibitor. Conclusions We concluded from this study that B.infantis alleviated GBS partly through PD-1.
first_indexed 2024-04-10T19:42:36Z
format Article
id doaj.art-fa8aa95bfc894a6389468d810f87d386
institution Directory Open Access Journal
issn 1471-2377
language English
last_indexed 2024-04-10T19:42:36Z
publishDate 2023-01-01
publisher BMC
record_format Article
series BMC Neurology
spelling doaj.art-fa8aa95bfc894a6389468d810f87d3862023-01-29T12:15:37ZengBMCBMC Neurology1471-23772023-01-012311810.1186/s12883-022-03046-wB.infantis enhances immunotherapy for Guillain-Barre syndrome through regulating PD-1Peng Shi0Di Nian1Hongdang Qu2Ming Ye3Chun Wang4Li Li5Qian Li6Department of Neurology, first Affiliated Hospital of Bengbu Medical CollegeDepartment of Medical Examination, Bengbu Medical CollegeDepartment of Neurology, first Affiliated Hospital of Bengbu Medical CollegeDepartment of Neurology, first Affiliated Hospital of Bengbu Medical CollegeDepartment of Neurology, first Affiliated Hospital of Bengbu Medical CollegeDepartment of Neurology, first Affiliated Hospital of Bengbu Medical CollegeDepartment of Neurology, first Affiliated Hospital of Bengbu Medical CollegeAbstract Background Guillain-Barré syndrome (GBS) is a rare, autoimmune disease. B.infantis is reported to be effective in alleviating GBS by regulating abnormal function of T helper (Th) cells. Objectives In this study, T cells were isolated from healthy and GBS patients. The therapeutic effect of Bifidobacterium infantis (B.infantis) and whether it is achieved by PD-1 was examined at cellular and animal models. Methods We used CCK-8, flow cytometry and real-time PCR to determine the differentiation of T cell subsets at cellular level. Then, an experimental autoimmune neuritis (EAN) animal model using six-week SD rats (n = 30, male) weighing 180–200 g was established to support the role of B. infantis in GBS through PD-1. Results B. infantis inhibited the proliferation and promoted apoptosis of T cells from GBS. At the same time, the expression levels of PD-1 increased, which was correlated with decreased T-bet (Th1) and ROR-γt (Th17) and increased Foxp3 (Treg) expression. Moreover, B. infantis alleviated the symptoms of GBS. Th1 and Th17 cells decreased while Treg cells increased after B. infantis treatment, which could be partly abrogated by PD-1 inhibitor. Conclusions We concluded from this study that B.infantis alleviated GBS partly through PD-1.https://doi.org/10.1186/s12883-022-03046-wGuillain-Barré syndromeB. infantis,experimental autoimmune neuritis animal modelT helper cellsPD-1
spellingShingle Peng Shi
Di Nian
Hongdang Qu
Ming Ye
Chun Wang
Li Li
Qian Li
B.infantis enhances immunotherapy for Guillain-Barre syndrome through regulating PD-1
BMC Neurology
Guillain-Barré syndrome
B. infantis,experimental autoimmune neuritis animal model
T helper cells
PD-1
title B.infantis enhances immunotherapy for Guillain-Barre syndrome through regulating PD-1
title_full B.infantis enhances immunotherapy for Guillain-Barre syndrome through regulating PD-1
title_fullStr B.infantis enhances immunotherapy for Guillain-Barre syndrome through regulating PD-1
title_full_unstemmed B.infantis enhances immunotherapy for Guillain-Barre syndrome through regulating PD-1
title_short B.infantis enhances immunotherapy for Guillain-Barre syndrome through regulating PD-1
title_sort b infantis enhances immunotherapy for guillain barre syndrome through regulating pd 1
topic Guillain-Barré syndrome
B. infantis,experimental autoimmune neuritis animal model
T helper cells
PD-1
url https://doi.org/10.1186/s12883-022-03046-w
work_keys_str_mv AT pengshi binfantisenhancesimmunotherapyforguillainbarresyndromethroughregulatingpd1
AT dinian binfantisenhancesimmunotherapyforguillainbarresyndromethroughregulatingpd1
AT hongdangqu binfantisenhancesimmunotherapyforguillainbarresyndromethroughregulatingpd1
AT mingye binfantisenhancesimmunotherapyforguillainbarresyndromethroughregulatingpd1
AT chunwang binfantisenhancesimmunotherapyforguillainbarresyndromethroughregulatingpd1
AT lili binfantisenhancesimmunotherapyforguillainbarresyndromethroughregulatingpd1
AT qianli binfantisenhancesimmunotherapyforguillainbarresyndromethroughregulatingpd1